CCL20 and major depressive disorder: This emphasizes the role of TRAIL and CCL20 in the link between innate and adaptive immune system, potentially also in mental health and is in line with observations of increased NMDAR antibodies in patients with schizophrenia and major depressive disorder, providing a link to autoimmunity as pathomechanisms in mental illness32,55.